Urgent MADAP Repeal Update – June 10, 2022

June 10, 2022 

This is to inform our stakeholders that the Notice of Final Action for COMAR 10.18.10 (Urgent MADAP) was printed in the June 3, 2022 Maryland Register with an effective date of June 13, 2022. Thereby effective June 13, 2022, MADAP will no longer accept Urgent MADAP applications dated June 13th and any dates thereafter. Any Urgent MADAP applications received and dated prior to June 13th will be processed according to policy. 

As noted during the listening session on October 4, 2021, the repeal of Urgent MADAP and its associated regulations will not affect the provision of MADAP. Eligible Maryland residents who require access to antiretroviral therapy will still be able to enroll with and participate in MADAP.  The Temporary Assistance (TAP) program nor MADAP Plus are impacted by this repeal. As such MADAP will continue to process applications according to policy for both of those programs.

This repeal is the result of recent policy change from the Health Resources and Services Administration (HRSA), which noted Urgent MADAP is currently non-compliant with federal Ryan White funding provisions, and that all federal Ryan White funding could be discontinued if Urgent MADAP is not terminated. Despite the federal requirement to terminate this enrollment option, MDH will continue to support Marylanders’ access to health coverage and pharmaceuticals through MADAP.

Any questions related to the legislative process associated with the repeal of COMAR 10.18.10 should be directed to Jody Sheely at Jody.Sheely@maryland.gov 

For any questions or concerns that you may have pertaining to MADAP operations, please contact the MADAP office at 410-767-6535 or send us an email to client.services@maryland.gov.

View Resource